ChartInsight

Nektar Therapeutics Financials

Revenue:
Net income:
Diluted EPS:

All values below without a dollar sign ($) are in millions (1,000,000) except for Earnings Per Share. Sourced from Nektar Therapeutics SEC filings. All data provided as-is without any warranty. Check original SEC filings before making any investment decision.

Income Statement

Quarter EndingRevenue, NetResearch and Development ExpenseOperating Income (Loss)Nonoperating Income (Expense)Net Income (Loss) Attributable to ParentEarnings Per Share, DilutedEarnings Per Share, BasicWeighted Average Number of Shares Outstanding, BasicWeighted Average Number of Shares Outstanding, Diluted
2018 Jun 8897429715.335.67171182
2018 Mar3899-87-9-96    
2017 Dec9581-24-10-34-0.21-0.21  
2017 Sep1536669-8610.370.39156163
2017 Jun3560-51-9-60-0.39-0.39  
2017 Mar2561-54-9-64-0.42-0.42  
2016 Dec3750-32-10-42-0.28-0.28  
2016 Sep3652-33-10-43-0.32-0.32137137
2016 Jun3352-38-10-49-0.36-0.36  
2016 Mar5949-9-10-19-0.14-0.14136136
2015 Dec3947-29-25-54-0.4-0.4  
2015 Sep60430-9-8-0.06-0.06133133
2015 Jun2345-43-9-53-0.4-0.4  
2015 Mar1094743-9340.250.26131136
2014 Dec2038-37-9-46-0.35-0.35  
2014 Sep1333480-9710.530.55128132
2014 Jun2937-23-10-33-0.26-0.26  
2014 Mar2038-36-10-46-0.37-0.37124124
2013 Dec3148-36-10-48-0.41-0.41  
2013 Sep6144-7-10-17-0.14-0.14116116
2013 Jun3452-33-10-43-0.37-0.37  
2013 Mar2346-45-9-55-0.48-0.48  
2012 Dec2146-43-10-53    
2012 Sep1834-33-10-44    
2012 Jun2433-27-7-34    
2012 Mar1835-38-3-41    
2011 Dec1633-34-2-37    
2011 Sep2731-21-3-24    
2011 Jun1732-34-2-36    
2011 Mar1130-34-2-36    
2010 Dec4531-21-2-23    
2010 Sep3828-6-2-9    
2010 Jun43262-2-1    
2010 Mar3323-3-2-6    

Cash Flow

Quarter EndingPayments to Acquire Property, Plant, and EquipmentIncrease (Decrease) in Other Operating LiabilitiesIncrease (Decrease) in Other Operating AssetsIncrease (Decrease) in InventoriesIncrease (Decrease) in Deferred RevenueIncrease (Decrease) in Accounts ReceivableIncrease (Decrease) in Accounts PayableIncome Tax Expense (Benefit)Cash and Cash Equivalents, Period Increase (Decrease)
2018 Jun       4 
2018 Mar11-20-406030
2017 Dec607-2-383-20 
2017 Sep       0 
2017 Jun       0 
2017 Mar4-3-2210-1440-36
2016 Dec5-650-11-2410 
2016 Sep       0 
2016 Jun       0 
2016 Mar22-40-7200017
2015 Dec10-74-1-2017-30 
2015 Sep       0 
2015 Jun       0 
2015 Mar110-302-120117
2014 Dec5-1330120-1 
2014 Sep       0 
2014 Jun       0 
2014 Mar5-11-1-60-60-7
2013 Dec413-3-5-15-152 
2013 Sep       0 
2013 Jun       0 
2013 Mar0-4-403-2103
2012 Dec94-24-13-510 
2012 Sep       0 
2012 Jun       0 
2012 Mar2-1-4136-10133
2011 Dec61111-15301 
2011 Sep       0 
2011 Jun       0 
2011 Mar4-214-3-23-305
2010 Dec271-1-1-201730 
2010 Sep       0 
2010 Jun       0 
2010 Mar4-112-27320-29

Assets

Quarter EndingCash and Cash Equivalents, at Carrying ValueAvailable-for-sale SecuritiesAccounts Receivable, Net, CurrentInventory, NetAssets, CurrentProperty, Plant and Equipment, NetGoodwillDeferred Revenue, NoncurrentDeferred Revenue, CurrentAssets
2018 Jun9111,99635121,9064577  2,313
2018 Mar35298161133646771320497
2017 Dec534751132747771919509
2017 Sep3838231438362775625582
2017 Jun1629241128865774913476
2017 Mar2333621338167775224528
2016 Dec60331161142666775214569
2016 Sep63187141128366775714425
2016 Jun56216281031868776016463
2016 Mar73213401134570776017492
2015 Dec56250201135071776221502
2015 Sep1924631028673776921449
2015 Jun2123141030272777423457
2015 Mar12917131334769777825499
2014 Dec1222541328870777724442
2014 Sep32205461232469778325477
2014 Jun3124731429871778925478
2014 Mar3225221330573777724487
2013 Dec3919821325867778224435
2013 Sep6512251520865778221383
2013 Jun4117262023468779422413
2013 Mar29 41826770779823448
2012 Dec2525261831572779722498
2012 Sep10319417347737710223541
2012 Jun1363411115468747710821668
2012 Mar1483501114421767711120695
2011 Dec15400513277797710820607
2011 Sep434151311298827711320648
2011 Jun12470810389857711820671
2011 Mar22 212539887712320704
2010 Dec18298257354907712521521
2010 Sep13         
2010 Jun23         
2010 Mar21         

© ChartInsight 2018, Seattle, WA